Coronavirus

>

Latest News

AstraZeneca’s Investigational COVID-19 Prevention Drug Reduces Risk of Infection in Immunocompromised Persons / Image credit: ©Sundry Phtography/AdobeStock
AstraZeneca’s Investigational COVID-19 Prevention Drug Reduces Risk of Infection in Immunocompromised Persons

May 16th 2024

Sipavibart met both dual primary endpoints in the SUPERNOVA phase 3 trial.

COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone: Daily Dose / image credit: ©New Africa/AdobeStock
COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone: Daily Dose

April 30th 2024

Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone
Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone

April 22nd 2024

RSV Disease Severity Comparable to Unvaccinated COVID-19, Flu: Daily Dose / image credit: ©New Africa/AdobeStock
RSV Disease Severity Comparable to Unvaccinated COVID-19, Flu: Daily Dose

April 18th 2024

RSV Disease Severity Comparable to Unvaccinated COVID-19, Influenza: New Research / image credit older man in hospital ©auremar/stock.adobe.com
RSV Disease Severity Comparable to Unvaccinated COVID-19, Influenza: New Research

April 11th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.